Data Presented at WORLDSymposium Reinforces Robust Rare Disease Pipeline and Highlights Additional Clinical Data for Investigational Avalglucosidase Alfa in Pompe Disease
February 2, 2021 -- Data with investigational enzyme replacement therapy avalglucosidase alfa in late-onset Pompe disease (LOPD) and infantile-onset Pompe disease (IOPD) will be featured as platform and poster presentations at the 17th annual... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 2, 2021 Category: Pharmaceuticals Source Type: clinical trials

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
Conditions:   Rare Diseases;   Genetic Predisposition Intervention:   Genetic: Retrospective data analysis Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2021 Category: Research Source Type: clinical trials